F-Prime Capital

Investor type

VC

Founded

1969

AUM

$4 500 M

Location

Cambridge, Massachusetts, United States

Investment Ticket

$0-1 m

Investment Stage

Series A Seed Series B Late Stage (Series C+)

Region of investment

Europe North America Asia
Investor profile last updated: 26 August, 2026

Profile

F-Prime Capital is a venture capital firm based in the United States. They have built a seasoned team consisting of scientists, engineers, physicians, operators, and investors, who together bring a wealth of real-world expertise to the companies they invest in. The firm focuses on accelerating the growth of their portfolio companies, driven by a shared vision of innovation and impact.

F-Prime Capital invests in a variety of sectors including life sciences, technology, healthtech and services, and crypto. They target companies at various stages of development, providing support to businesses from concept to growth. The firm holds a robust portfolio with investments in numerous breakthrough companies within their stated sectors.

Some notable portfolio companies under F-Prime Capital include Innovent Biologics - a Chinese biopharmaceutical firm, Iora Health - a network for primary care, AviadioBio - a gene therapy company, Lighthouse - a technology-enabled personalized learning services, and PatientPing - a provider of real-time patient data for healthcare providers. These investments reflect F-Prime Capital's commitment to fostering innovation across different sectors.

Industry

Business Services (B2B) Education Edtech Fashion/Beauty Financial Services Fintech Food and Beverage TravelTech Foodtech Gaming Healthcare Services Industrial IT Services Medical Devices Pharmaceuticals SaaS Security Software Blockchain/Crypto AI MedTech Technology Life Sciences HealthTech Biotechnology

F-Prime Capital Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
F-Prime Capital Partners Life Sciences Fund VI LP
Venture Capital (VC)
Biotechnology
Healthcare Services
Medical Devices
Pharmaceuticals
AI
HealthTech
Pre-seed
Seed
North America
Europe
Asia
$5-10 m
June 2012

Contacts

Upgrade to see contacts
Name
Title
Email
avatar
8hEtA3msrHDfnL0v 8hEtA3msrHDfnL0v
8hEtA3msrHDfnL0v
avatar
8hEtA3msrHDfnL0v 8hEtA3msrHDfnL0v
8hEtA3msrHDfnL0v
avatar
8hEtA3msrHDfnL0v 8hEtA3msrHDfnL0v
8hEtA3msrHDfnL0v
avatar
8hEtA3msrHDfnL0v 8hEtA3msrHDfnL0v
8hEtA3msrHDfnL0v
avatar
8hEtA3msrHDfnL0v 8hEtA3msrHDfnL0v
8hEtA3msrHDfnL0v
If there are no contacts of this investor, please write to us, we will try to find them as soon as possible and get back to you!

FAQs about F-Prime Capital

F-Prime Capital is located in Cambridge, Massachusetts, United States.
F-Prime Capital was founded in 1969.
F-Prime Capital invests in companies and startups in Business Services (B2B), Education, Edtech, Fashion/Beauty, Financial Services, Fintech, Food and Beverage, TravelTech, Foodtech, Gaming, Healthcare Services, Industrial, IT Services, Medical Devices, Pharmaceuticals, SaaS, Security, Software, Blockchain/Crypto, AI, MedTech, Technology, Life Sciences, HealthTech, Biotechnology.
F-Prime Capital invests in companies and startups in Europe, North America, Asia.
F-Prime Capital invests in companies and startups at Series A, Seed, Series B, Late Stage (Series C+).
F-Prime Capital usually invests $0-1 m on average.
F-Prime Capital has around $4 500m assets under management.
F-Prime Capital last fund was created/launched in 2012-06-06